COVID-19 immunisation among individuals with opioid use disorder in Ontario: a population-based cohort study
Open Access
- 1 July 2025
- journal article
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e002755
Abstract
Background: The COVID-19 pandemic exacerbated health inequities, particularly among individuals with opioid use disorder (OUD). Disparities in vaccine uptake among people with OUD remain poorly understood. This study assessed COVID-19 immunisation rates among individuals with OUD compared with the general population in Ontario, Canada. Methods: This population-based retrospective cohort study used linked administrative health data to compare COVID-19 vaccination rates between individuals diagnosed with OUD and a 10% random sample of individuals without OUD. Ontario residents aged >15 years with continuous healthcare coverage as of the censor date, 16 March 2020, were included. Inverse Probability of Treatment Weighting (IPTW) was applied to balance confounders, and Cox proportional hazards models estimated adjusted HRs (aHRs) for receiving two and three or more vaccine doses. Results: The cohort included 105 733 individuals with OUD and 1 185 993 without OUD. Individuals with OUD had a lower hazard of receiving two vaccine doses (aHR: 0.75, 95% CI 0.73 to 0.76) and three or more doses (aHR: 0.69, 95% CI 0.67 to 0.70). The rate of two-dose and three-dose vaccination was also lower among those with OUD (115.3 vs 149.0 per 100 000 person-years and 44.7 vs 77.5 per 100 000 person-years). Conclusion: Individuals with OUD had lower COVID-19 vaccination rates, suggesting barriers to access and uptake. Addressing these disparities through targeted interventions is crucial for equitable public health responses.Keywords
Funding Information
- Ontario Ministry of Health (Not Applicable)
- the Ministry of Long-Term Care (Not Applicable)
- Canadian Institutes of Health Research (Funding Reference Number (FRN): 148817)
This publication has 15 references indexed in Scilit:
- Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort studyAddiction, 2022
- Uptake, barriers and correlates of influenza vaccination among people who inject drugs in AustraliaDrug and Alcohol Dependence, 2021
- Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escapeNature Reviews Immunology, 2021
- Opioid use disorder treatment for people experiencing homelessness: A scoping reviewDrug and Alcohol Dependence, 2021
- Identifying Missed Opportunities for Routine Vaccination among People Who Use DrugsInternational Journal of Environmental Research and Public Health, 2021
- Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020Vaccine, 2021
- COVID-19 and the ‘rediscovery’ of health inequitiesInternational Journal of Epidemiology, 2020
- COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United StatesMolecular Psychiatry, 2020
- Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C InfectionPublic Health Reports®, 2019
- Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012Vaccine, 2014